In human melanoma cells (SK-MEL-1), Perdomo et al. [53] demonstrate that, as melatonin promotes GSK-3β dephosphorylation at serine 9 via Akt pathway inhibition, the activation of GSK-3β by melatonin results in an increase in ROS production (Figure 2). The gene discussed is GSK3B; the disease is melanoma.